AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

Here is a blueprint for architecting real-time systems that scale without sacrificing speed. A common mistake I see in ...

Finding something new to watch on Netflix is hard enough when the home screen always suggests the same popular titles. But what would you say if there was a way to make finding new and exciting things ...